$Notable Labs (NTBL.US)$ NEWS Notable Labs Presents the Desi...
NEWS
Notable Labs Presents the Design Plan for the PPMP-Enabled Phase 2 Trial with Volasertib for Relapsed/Refractory AML at AACR 2024
Notable Labs, presents the design for a Phase 2 trial with volasertib and decitabine in patients with relapsed/refractory AML at AACR 2024. The company aims to predict responders using their PPMP and develop a companion diagnostic test.
Poster outlines the parameters for developing a flow-cytometry-based PPMP as a companion diagnostic to predict volasertib responders, based on a proof-of-concept study using 41 primary acute myeloid leukemia (AML) samples
Plans to incorporate a dose optimization prelude to enhance patient response and tolerability also outlined in the poster
Plans to incorporate a dose optimization prelude to enhance patient response and tolerability also outlined in the poster
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
463Followers
66Following
2948Visitors
Follow
luckme : He hasn't started yet. The smallest mini stock is easy to control